Notice2024-14481
Request for Information (RFI): Inviting Comments and Suggestions on an ODS Strategic Plan 2025-2029: A Blueprint for a Coordinated Dietary Supplement Research Agenda at NIH
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 1, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
The National Institutes of Health (NIH), Office of Dietary Supplements (ODS) is continuing to use a structured planning process to develop its five-year strategic plans. After a new director joined ODS in July 2023 a new strategic plan for 2025-2029 was developed titled "A Blueprint for a Coordinated Dietary Supplement Research Agenda at NIH." ODS is committed to engaging its partners and other interested parties including representatives of the scientific community, industry, other federal agencies, policymakers, and the public in the strategic planning process by soliciting their comments on the draft ODS Strategic Plan for Fiscal Years (CY) 2025-2029.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 126 (Monday, July 1, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 126 (Monday, July 1, 2024)]
[Notices]
[Pages 54472-54473]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-14481]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Request for Information (RFI): Inviting Comments and Suggestions
on an ODS Strategic Plan 2025-2029: A Blueprint for a Coordinated
Dietary Supplement Research Agenda at NIH
AGENCY: National Institutes of Health, HHS.
ACTION: Request for information.
-----------------------------------------------------------------------
SUMMARY: The National Institutes of Health (NIH), Office of Dietary
Supplements (ODS) is continuing to use a structured planning process to
develop its five-year strategic plans. After a new director joined ODS
in July 2023 a new strategic plan for 2025-2029 was developed titled
``A Blueprint for a Coordinated Dietary Supplement Research Agenda at
NIH.'' ODS is committed to engaging its partners and other interested
parties including representatives of the scientific community,
industry, other federal agencies, policymakers, and the public in the
strategic planning process by soliciting their comments on the draft
ODS Strategic Plan for Fiscal Years (CY) 2025-2029.
DATES: The RFI is open for public comment for a period of 60 days. To
ensure consideration, comments must be submitted by August 30, 2024.
ADDRESSES: All comments must be submitted electronically to
<a href="/cdn-cgi/l/email-protection#dd92998eadb1bcb39db2b9f3b3b4b5f3bab2ab"><span class="__cf_email__" data-cfemail="eba4afb89b878a85ab848fc5858283c58c849d">[email protected]</span></a>. You will receive an electronic confirmation
acknowledging receipt of your response.
FOR FURTHER INFORMATION CONTACT: Barbara Cohen, Ph.D., at
<a href="/cdn-cgi/l/email-protection#450a01163529242b052a216b2b2c2d6b222a33"><span class="__cf_email__" data-cfemail="145b50476478757a547b703a7a7d7c3a737b62">[email protected]</span></a> or (301) 435-2920.
SUPPLEMENTARY INFORMATION: This notice is in accordance with the 21st
Century Cures Act, wherein NIH institutes are required to regularly
update their strategic plans. The purpose of the CY 2025-2029 ODS
Strategic Plan (https://ods.od.nih.gov/
[[Page 54473]]
About/StrategicPlan.aspx) is to communicate how ODS will advance its
mission to coordinate cutting-edge dietary supplement research across
NIH Institutes, Centers, and Offices (ICOs) and other federal agencies
to foster knowledge and optimize health across the lifespan. The plan
articulates ODS' priorities as follows:
<bullet> To coordinate and support dietary supplement research
focused on biological, population, and product sciences.
<bullet> To develop NIH dietary supplement initiatives that
incorporate rigorous dietary supplement research methods and make best
use of available NIH funding mechanisms.
<bullet> To support ODS programs and develop and disseminate
dietary supplement research findings and research resources to ODS
audiences.
ODS has completed a draft of its Five-Year Strategic Plan for CY
2025-2029 (<a href="https://ods.od.nih.gov/About/StrategicPlan.aspx">https://ods.od.nih.gov/About/StrategicPlan.aspx</a>) and is
interested in receiving feedback from all interested parties on the
following:
<bullet> Any additional emerging public health issues or knowledge
gaps that ODS can help address.
<bullet> Partnerships NIH should pursue, both inside and outside of
government, to advance research on dietary supplements.
ODS encourages organizations to submit a single response reflective
of the views of the organization as a whole.
Responses to this RFI are voluntary and may be submitted
anonymously. Please do not include any personally identifiable
information or any information that you do not wish to make public.
Proprietary, classified, confidential, or sensitive information should
not be included in your response. NIH will use the information
submitted in response to this Request for Information (RFI) at its
discretion. NIH reserves the right to use any submitted information on
public websites, in reports, in summaries of the state of the science,
in any possible resultant solicitation(s), grant(s), or cooperative
agreement(s), or in the development of future funding opportunity
announcements. This RFI is for informational and planning purposes only
and is not a solicitation for applications or an obligation on the part
of the Government to provide support for any ideas identified in
response to it. Please note that the Government will not pay for the
preparation of any information submitted or for the use of that
information.
No basis for claims against the U.S. Government shall arise as a
result of a response to this RFI or from the Government's use of such
information. Additionally, the Government cannot guarantee the
confidentiality of the information provided.
Dated: June 20, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2024-14481 Filed 6-28-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 1, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.